We are live on !
Find out more
Cetera Advisors Portfolio holdings
AUM
$12.7B
Turnover
31.41%
1-Year Est. Return
22.7%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+22.7%
3 Year Est. Return
+27.57%
5 Year Est. Return
+84.51%
10 Year Est. Return
+153.37%
AUM
$12.7B
AUM Growth
+$5.47B
(+76%)
Cap. Flow
+$4.76B
Cap. Flow % of AUM
Cap. Flow %
37.54%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
2,499
New
711
Increased
1,442
Reduced
226
Closed
74
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.7
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$150M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$111M |
| 5 |
NVIDIA
NVDA
|
+$85.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$60.5M |
| 2 |
iShares Russell Mid-Cap ETF
IWR
|
+$7.89M |
| 3 |
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
|
+$7.32M |
| 4 |
FT Vest US Equity Moderate Buffer ETF February
GFEB
|
+$6.14M |
| 5 |
Pacer Global Cash Cows Dividend ETF
GCOW
|
+$5.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.49% |
| 2 | Technology | 11.25% |
| 3 | Financials | 5.19% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Healthcare | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Americas Gold and Silver
USAS
$1.08B
| $15K | ﹤0.01% |
+27,259
| New | +$15.2K |
2024 Q1
0 quarters
|
|
2377
Perspective Therapeutics
CATX
$258M
| $14.9K | ﹤0.01% |
+1,250
| New | +$10.7K |
2024 Q1
0 quarters
|
|
2378
DELISTED
Chimerix, Inc.
CMRX
| $14.8K | ﹤0.01% |
+13,972
| New | +$14.5K |
2024 Q1
0 quarters
|
|
2379
DELISTED
Nikola Corporation Common Stock
NKLA
| $14.1K | ﹤0.01% |
+452
| New | +$9.7K |
2024 Q1
0 quarters
|
|
2380
DELISTED
Enviva Inc.
EVA
| $12.1K | ﹤0.01% |
27,450
| – | – |
2023 Q4
1 quarter
|
|
2381
Gossamer Bio
GOSS
$57.9M
| $11.8K | ﹤0.01% |
+125
| New | +$11K |
2024 Q1
0 quarters
|
|
2382
BioLineRX
BLRX
$10.3M
| $11.8K | ﹤0.01% |
+264
| New | +$13.2K |
2024 Q1
0 quarters
|
|
2383
Gevo
GEVO
$282M
| $11.5K | ﹤0.01% |
15,001
+3,000
| +25% | +$2.61K |
2023 Q3
2 quarters
|
|
2384
Nektar Therapeutics
NKTR
$1.32B
| $11.2K | ﹤0.01% |
800
-20
| -2% | -$209 |
2021 Q4
9 quarters
|
|
|
2385
PUT
Apple
AAPL
$5.08T
| $10.6K | ﹤0.01% |
+1,500
| New | +$273K |
2024 Q1
0 quarters
|
|
2386
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $10.5K | ﹤0.01% |
+600
| New | +$299K |
2024 Q1
0 quarters
|
|
2387
PUT
Eli Lilly
LLY
$1.16T
| $7.65K | ﹤0.01% |
+1,000
| New | +$712K |
2024 Q1
0 quarters
|
|
2388
Senseonics Holdings Inc
SENS
$391M
| $7.6K | ﹤0.01% |
715
+120
| +20% | +$1.39K |
2017 Q1
28 quarters
|
|
2389
Dogwood Therapeutics
DWTX
$38.1M
| $5.7K | ﹤0.01% |
476
-66
| -12% | -$741 |
2021 Q1
12 quarters
|
|
2390
DELISTED
Paysafe Ltd Warrants
PSFE.WS
| $3.73K | ﹤0.01% |
+118,900
| New | +$3.44K |
2024 Q1
0 quarters
|
|
|
AAU
2391
DELISTED
Almaden Minerals Ltd
AAU
| $3.36K | ﹤0.01% |
24,000
+12,000
| +100% | +$1.64K |
2023 Q4
1 quarter
|
|
2392
DELISTED
Camber Energy, Inc
CEI
| $2.9K | ﹤0.01% |
+14,265
| New | +$2.74K |
2024 Q1
0 quarters
|
|
2393
DELISTED
Zomedica Corp.
ZOM
| $2.63K | ﹤0.01% |
+18,052
| New | +$2.52K |
2024 Q1
0 quarters
|
|
2394
SkyAI Inc
SKYAW
$400K
| $1.32K | ﹤0.01% |
+16,500
| New | +$1.75K |
2024 Q1
0 quarters
|
|
2395
Nutex Health
NUTX
$1.41B
| $966 | ﹤0.01% |
+67
| New | +$1.35K |
2024 Q1
0 quarters
|
|
|
2396
PUT
Invesco QQQ Trust
QQQ
$475B
| $120 | ﹤0.01% |
1,200
| – | – |
2023 Q2
3 quarters
|
|
2397
PUT
Affirm
AFRM
$24.4B
| – | – |
-4,400
| Closed | -$25.1K | – |
|
2398
American Superconductor
AMSC
$1.21B
| – | – |
-41,021
| Closed | -$457K | – |
|
2399
Arcos Dorados Holdings
ARCO
$1.69B
| – | – |
-36,478
| Closed | -$463K | – |
|
2400
American Resources Corp
AREC
$119M
| – | – |
-10,500
| Closed | -$15.6K | – |
|
Similar funds
Cetera Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Cetera Advisors held 2,499 positions worth $12.7B, up 76% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cetera Advisors deployed $4.76B of net new capital in Q1 2024, opening 711 new positions and adding to 1,442 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 641,610 shares worth $28.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 67% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $60.5M trimmed.
- Cetera Advisors's largest Q1 2024 buy was BlackRock US Equity Factor Rotation ETF: 641,610 shares worth $28.5M.
- Cetera Advisors added most to Apple in Q1 2024, an estimated $201M increase.
- Cetera Advisors's biggest Q1 2024 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $60.5M.
- Cetera Advisors fully exited FT Vest US Equity Buffer & Premium Income ETF September in Q1 2024, selling an estimated $4.38M.
- Cetera Advisors's ten largest holdings make up 18% of its $12.7B portfolio in Q1 2024.
- Cetera Advisors opened 711 new positions and closed 74 in Q1 2024.
- Cetera Advisors's portfolio value rose 76% quarter-over-quarter to $12.7B.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.